SULPERAZON

This brand name is authorized in Hong Kong, Japan, Lithuania, Poland

Active ingredients

The drug SULPERAZON contains a combination of these active pharmaceutical ingredients (APIs):

1 Sulbactam UNII S4TF6I2330 - SULBACTAM

Read about Sulbactam

2 Cefoperazone UNII 5FQG9774WD - CEFOPERAZONE SODIUM

Cefoperazone, a third-generation cephalosporin, interferes with cell wall synthesis by binding to the penicillin-binding proteins (PBPs), thus preventing cross-linking of nascent peptidoglycan. Cefoperazone is stable to penicillinases and has a high degree of stability to many beta-lactamases produced by gram-negative bacteria. Read about Cefoperazone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DD62	Cefoperazone, combinations	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD62

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 32893, 56664
Country: JP	医薬品医療機器総合機構	Identifier(s): 6139500F1024, 6139500F2020, 6139500G1070
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010464
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100127743, 100127750, 100324142, 100444840